Detalhe da pesquisa
1.
Curing HIV: Seeking to Target and Clear Persistent Infection.
Cell
; 181(1): 189-206, 2020 04 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32220311
2.
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
PLoS Pathog
; 20(4): e1011680, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38635853
3.
Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy.
J Immunol
; 212(10): 1564-1578, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38551350
4.
HIV post-treatment controllers have distinct immunological and virological features.
Proc Natl Acad Sci U S A
; 120(11): e2218960120, 2023 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36877848
5.
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo.
J Infect Dis
; 229(4): 1123-1130, 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37969014
6.
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy.
J Infect Dis
; 229(3): 743-752, 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38349333
7.
Characterization of treatment resistance and viral kinetics in the setting of single- versus dual-active monoclonal antibodies against SARS-CoV-2.
J Infect Dis
; 2024 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38716969
8.
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
N Engl J Med
; 385(7): 595-608, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34379922
9.
COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina.
J Antimicrob Chemother
; 79(4): 859-867, 2024 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38380946
10.
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
Ann Intern Med
; 176(3): 348-354, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36802755
11.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Ann Intern Med
; 176(5): 658-666, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37068272
12.
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
J Infect Dis
; 228(Suppl 2): S77-S82, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650231
13.
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
J Infect Dis
; 228(Suppl 2): S92-S100, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650234
14.
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
J Infect Dis
; 228(Suppl 2): S83-S91, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650237
15.
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
J Infect Dis
; 228(2): 133-142, 2023 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36661240
16.
Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy.
J Infect Dis
; 227(12): 1376-1380, 2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36763044
17.
Evaluating Clinic-Based Interventions to Reduce Racial Differences in Mortality Among People With Human Immunodeficiency Virus in the United States.
J Infect Dis
; 228(12): 1690-1698, 2023 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37437108
18.
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
J Infect Dis
; 228(Suppl 2): S117-S125, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650230
19.
Variant-Specific Viral Kinetics in Acute COVID-19.
J Infect Dis
; 228(Suppl 2): S136-S143, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650233
20.
Immune Status and SARS-CoV-2 Viral Dynamics.
J Infect Dis
; 228(Suppl 2): S111-S116, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650232